GWSG
DYN icon

GPS Wealth Strategies Group’s Dyne Therapeutics DYN Stock Holding History

GPS Wealth Strategies Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$5.06K – 832
2025
Q3 		$5.06K Hold
400
– – ﹤0.01% 1258
2025
Q2 		$3.81K Hold
400
– – ﹤0.01% 1263
2025
Q1 		$4.18K Hold
400
– – ﹤0.01% 1197
2024
Q4 		$9.42K Hold
400
– – ﹤0.01% 963
2024
Q3 		$14.4K Hold
400
– – ﹤0.01% 872
2024
Q2 		$14.1K Hold
400
– – ﹤0.01% 836
2024
Q1 		$11.4K Buy
+400
New +$9.05K ﹤0.01% 828

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

GPS Wealth Strategies Group's DYN Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Dyne Therapeutics (DYN) in Q4 2025, closing a stake of 400 shares — an estimated $5.06K sold.

GPS Wealth Strategies Group first reported a position in DYN in Q1 2024 and held it in 7 quarters. The position peaked at $14.4K in Q3 2024. 232 funds tracked by Wall St. Rank hold DYN as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Dyne Therapeutics position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 400 Dyne Therapeutics shares in Q4 2025, an estimated $5.06K.
  • GPS Wealth Strategies Group first reported a position in Dyne Therapeutics in Q1 2024 and held it in 7 quarters.
  • GPS Wealth Strategies Group's Dyne Therapeutics position peaked at $14.4K in Q3 2024.
  • 232 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.